<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33647/2074-5982-16-1-42-55</article-id><article-id custom-type="elpub" pub-id-type="custom">scbmt-1173</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТОДЫ БИОМЕДИЦИНСКИХ ИССЛЕДОВАНИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>METHODS OF BIOMEDICAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Исследование и оценка молекулярно-генетических признаков экспрессии гена NFE2L2 при адаптации к физическим нагрузкам у мини-пигов</article-title><trans-title-group xml:lang="en"><trans-title>Study and Evaluation of Molecular Genetic Signs of the NFE2L2 Gene Expression during Adaptation to Physical Loads in Mini Pigs</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каркищенко</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Karkischenko</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каркищенко Владислав Николаевич – д.м.н.</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Vladislav N. Karkischenko – Dr. Sci. (Med.), Prof.</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">scbmt@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Наталья Владимировна</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Nataliya V. Petrova</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">m-sklad@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cтанкова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stankova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cтанкова Наталия Владимировна – к.б.н.</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Nataliya V. Stankova – Cand. Sci. (Biol.)</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">sinayva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cлободенюк</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Slobodenyuk</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cлободенюк Владимир Владимирович – к.б.н.</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Vladimir V. Slobodenyuk – Cand. Sci. (Biol.)</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алимкина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Alimkina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алимкина Оксана Владимировна</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Oksana V. Alimkina</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">alimkina@scbmt.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулакова</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulakova</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кулакова Мария Игоревна</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Mariya I. Kulakova</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">maryvoronova91@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasil’eva</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васильева Ирина Андреевна</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, владение 1</p></bio><bio xml:lang="en"><p>Irina A. Vasil’eva</p><p>143442, Moscow region, Krasnogorsk district, Svetlye gory village, building 1</p></bio><email xlink:type="simple">rozhstul@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУН «Научный центр биомедицинских технологий Федерального медико-биологического агентства России»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientiﬁc Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2020</year></pub-date><volume>16</volume><issue>1</issue><fpage>42</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каркищенко В.Н., Петрова Н.В., Cтанкова Н.В., Cлободенюк В.В., Алимкина О.В., Кулакова М.И., Васильева И.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Каркищенко В.Н., Петрова Н.В., Cтанкова Н.В., Cлободенюк В.В., Алимкина О.В., Кулакова М.И., Васильева И.А.</copyright-holder><copyright-holder xml:lang="en">Karkischenko V.N., Petrova N.V., Stankova N.V., Slobodenyuk V.V., Alimkina O.V., Kulakova M.I., Vasil’eva I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/1173">https://journal.scbmt.ru/jour/article/view/1173</self-uri><abstract><p>В статье показана экспрессия гена NFE2L2 (Nuclear Factor, Erythroid 2 Like 2) при адаптации к физическим нагрузкам (достижении оксидативного стресса) у мини-пигов. В эксперименте воспроизведены естественные условия оксидативного стресса у лабораторных животных (мини-пигов, 16 особей). Спортивная тренировка является оптимальной и естественной моделью усиленной диссимиляции как причины оксидативного стресса. Результаты исследования свидетельствуют, что ген NFE2L2, кодирующий фактор транскрипции Nrf2, активно экспрессируется в ответ на оксидативный стресс в клетках организма животных. Ген NFE2L2 может служить оценочным критерием при проведении молекулярно-генетических исследований работоспособности и выносливости для индивидуального отбора по группам. Он рекомендован для проведения исследований влияния фармакологических препаратов на восстановительные свойства организма при возможном выборе фармнутриентов и экстраполяции исследований на человека. Важным практическим результатом и показателем адаптации является повышение работоспособности. Возможность повлиять на экспрессию гена NFE2L2 может усилить способность организма к адаптации в условиях кислородного голодания.</p></abstract><trans-abstract xml:lang="en"><p>This article sets out to evaluate the expression of the NFE2L2 gene (Nuclear Factor, Erythroid 2 Like 2) when adapting to physical loads (achieving oxidative stress) in mini pigs. The conducted experiment reproduced natural conditions of oxidative stress in laboratory animals (16 mini pigs). Sports training is the most optimal and natural model of enhanced dissimilation as a cause of oxidative stress. The results of the study indicate that the NFE2L2 gene encoding the Nrf2 transcription factor is actively expressed in response to oxidative stress in animal cells. The NFE2L2 gene can serve as an evaluation criterion for molecular genetic studies of performance and endurance for individual selection by groups. Such evaluation can be recommended for studies aimed at revealing the effects of pharmacological drugs on the regenerative properties of the body, with the possible choice of pharmaceutical ingredients and extrapolation from animal studies to humans. An important practical result and an indicator of adaptation is increased performance. The possibility of affecting the expression of the NFE2L2 gene paves the way to enhancing the body’s ability to adapt to oxygen starvation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>оксидативный стресс</kwd><kwd>адаптация</kwd><kwd>выносливость</kwd><kwd>ДНК</kwd><kwd>ген NFE2L2</kwd><kwd>мини-пиги</kwd></kwd-group><kwd-group xml:lang="en"><kwd>oxidative stress</kwd><kwd>adaptation</kwd><kwd>endurance</kwd><kwd>DNA</kwd><kwd>NFE2L2 gene</kwd><kwd>mini pigs</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чечушков А.В., Ткачев В.О. Зенков Н.К., Меньщикова Е.Б. Участие редокс-чувствительной сигнальной системы Keap1/Nrf2/ARE в дифференцировке и активации Т-лимфоцитов. Бюллетень СО РАМН. 2012;32(5):21–27.</mixed-citation><mixed-citation xml:lang="en">Chechushkov A.V., Tkachev V.O. Zenkov N.K., Men’shchikova E.B. Uchastie redoks-chuvstvitel’noj signal’noj sistemy Keap1/Nrf2/ARE v differencirovke i aktivacii T-limfocitov [The participation of the redox-sensitive Keap1/Nrf2/ARE signaling system in the differentiation and activation of T-lymphocytes]. Bulletin of the Siberian Branch of the RAMS. 2012;32(5):21–27. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bobilev I., Novik V., Levi I., Shpilberg O., Levy J., Sharoni Y., et al. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells. Cancer Biology &amp; Therapy. 2011;11: 317–329.</mixed-citation><mixed-citation xml:lang="en">Bobilev I., Novik V., Levi I., Shpilberg O., Levy J., Sharoni Y., et al. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells. Cancer Biology &amp; Therapy. 2011;11: 317–329.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Halliwell B., Gutteridge M.C. Free Radicals in Biology and Medicine. Oxford University Press, 2000.</mixed-citation><mixed-citation xml:lang="en">Halliwell B., Gutteridge M.C. Free Radicals in Biology and Medicine. Oxford University Press, 2000.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Itoh К., Igarashi K., Hayashi N., Nishizawa M., Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maffamily proteins. Mol. Cell Biol. 1995;15(8):4184–4193.</mixed-citation><mixed-citation xml:lang="en">Itoh К., Igarashi K., Hayashi N., Nishizawa M., Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maffamily proteins. Mol. Cell Biol. 1995;15(8):4184–4193.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood. 2002;100:917–924.</mixed-citation><mixed-citation xml:lang="en">Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood. 2002;100:917–924.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sen C.K. The general case for redox control of wound repair. Wound Repair and Regeneration. 2003;11:431–438.</mixed-citation><mixed-citation xml:lang="en">Sen C.K. The general case for redox control of wound repair. Wound Repair and Regeneration. 2003;11:431–438.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Surh Y., Lee J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005;224(2):1–84.</mixed-citation><mixed-citation xml:lang="en">Surh Y., Lee J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005;224(2):1–84.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sykiotis G., Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell. 2008;14(1):76–85.</mixed-citation><mixed-citation xml:lang="en">Sykiotis G., Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell. 2008;14(1):76–85.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
